BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 25838233)

  • 1. Impact of renal function on changes of plaque characteristics in non-intervened coronary segments after rosuvastatin treatment in patients with angina pectoris and hypertension.
    Hong YJ; Jeong MH; Cho KH; Kim MC; Lee KJ; Kim KH; Kim HK; Jeong HC; Park KH; Sim DS; Kim JH; Ahn Y; Cho JG; Park JC; Kim SH; Kang JC
    Int J Cardiol; 2015; 187():286-7. PubMed ID: 25838233
    [No Abstract]   [Full Text] [Related]  

  • 2. Impact of baseline plaque components on plaque progression in nonintervened coronary segments in patients with angina pectoris on rosuvastatin 10 mg/day.
    Hong YJ; Jeong MH; Choi YH; Ma EH; Ko JS; Lee MG; Park KH; Sim DS; Yoon NS; Youn HJ; Kim KH; Park HW; Kim JH; Ahn Y; Cho JG; Park JC; Kang JC
    Am J Cardiol; 2010 Nov; 106(9):1241-7. PubMed ID: 21029819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of rosuvastatin versus atorvastatin on coronary atherosclerotic plaque volume - a systematic review and meta-analysis with trial sequential analysis of randomized control trials.
    Kumar A; Shariff M; Doshi R
    Eur J Prev Cardiol; 2020 Dec; 27(19):2138-2141. PubMed ID: 31382809
    [No Abstract]   [Full Text] [Related]  

  • 4. The ability of high dose rosuvastatin to improve plaque composition in non-intervened coronary arteries: rationale and design of the Integrated Biomarker and Imaging Study-3 (IBIS-3).
    Simsek C; Garcia-Garcia HM; van Geuns RJ; Magro M; Girasis C; van Mieghem N; Lenzen M; de Boer S; Regar E; van der Giessen W; Raichlen J; Duckers HJ; Zijlstra F; van der Steen T; Boersma E; Serruys PW;
    EuroIntervention; 2012 Jun; 8(2):235-41. PubMed ID: 22717926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of statin use before the onset of acute myocardial infarction on coronary plaque morphology of the culprit lesion.
    Hikita H; Kuroda S; Oosaka Y; Kawaguchi N; Nakashima E; Sugiyama T; Akiyama D; Kamiishi T; Kimura S; Takahashi Y; Kuwahara T; Sato A; Takahashi A; Isobe M
    Angiology; 2013 Jul; 64(5):375-8. PubMed ID: 22679133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plaque ruptures in stable angina pectoris compared with acute coronary syndrome.
    Hong MK; Mintz GS; Lee CW; Park KM; Lee BK; Kim YH; Kang DH; Cheong SS; Song JK; Kim JJ; Park SW; Park SJ
    Int J Cardiol; 2007 Jan; 114(1):78-82. PubMed ID: 16712982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural history of a coronary plaque followed by computed tomography.
    Inaba S; Okayama H; Kido T; Mochizuki T; Higaki J
    Eur Heart J Cardiovasc Imaging; 2012 Mar; 13(3):242. PubMed ID: 22271109
    [No Abstract]   [Full Text] [Related]  

  • 8. Should standard medical therapy for angina include a statin?
    Corti R; Fuster V
    Clin Cardiol; 2004 Oct; 27(10):547-51. PubMed ID: 15553303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How does lipid lowering prevent coronary events? New insights from human imaging trials.
    Libby P
    Eur Heart J; 2015 Feb; 36(8):472-4. PubMed ID: 25575600
    [No Abstract]   [Full Text] [Related]  

  • 10. Association between circulating matrix metalloproteinase levels and coronary plaque regression after acute coronary syndrome--subanalysis of the JAPAN-ACS study.
    Ogita M; Miyauchi K; Morimoto T; Daida H; Kimura T; Hiro T; Nakagawa Y; Yamagishi M; Ozaki Y; Matsuzaki M
    Atherosclerosis; 2013 Jan; 226(1):275-80. PubMed ID: 23159100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HMG-CoA reductase inhibitor (Statin) therapy and coronary atherosclerosis in Japanese subjects: role of high-density lipoprotein cholesterol.
    Tani S; Nagao K; Hirayama A
    Am J Cardiovasc Drugs; 2011 Dec; 11(6):411-7. PubMed ID: 22149320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of systemic inflammation with local inflammatory activity in non-culprit lesions: beneficial effect of statins.
    Toutouzas K; Drakopoulou M; Markou V; Karabelas I; Vaina S; Vavuranakis M; Tsiamis E; Tsioufis C; Androulakis A; Stefanadis C
    Int J Cardiol; 2007 Jul; 119(3):368-73. PubMed ID: 17258821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of statin drugs in acute coronary syndromes.
    Rackley CE
    Curr Atheroscler Rep; 2002 May; 4(3):161-3. PubMed ID: 11931712
    [No Abstract]   [Full Text] [Related]  

  • 14. Assessment of echo-attenuated plaque by optical coherence tomography and its impact on post-procedural creatine kinase-myocardial band elevation in elective stent implantation.
    Lee T; Kakuta T; Yonetsu T; Takahashi K; Yamamoto G; Iesaka Y; Fujiwara H; Isobe M
    JACC Cardiovasc Interv; 2011 May; 4(5):483-91. PubMed ID: 21596319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amelioration of high fat diet-induced nephropathy by cilostazol and rosuvastatin.
    Park JH; Choi BH; Ku SK; Kim DH; Jung KA; Oh E; Kwak MK
    Arch Pharm Res; 2017 Mar; 40(3):391-402. PubMed ID: 28084586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do systemic risk factors impact invasive findings from virtual histology? Insights from the international virtual histology registry.
    Philipp S; Böse D; Wijns W; Marso SP; Schwartz RS; König A; Lerman A; Garcia-Garcia HM; Serruys PW; Erbel R
    Eur Heart J; 2010 Jan; 31(2):196-202. PubMed ID: 19854730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of plaque characteristics in narrowings with ST-elevation myocardial infarction (STEMI), non-STEMI/unstable angina pectoris and stable coronary artery disease (from the ADAPT-DES IVUS Substudy).
    Dong L; Mintz GS; Witzenbichler B; Metzger DC; Rinaldi MJ; Duffy PL; Weisz G; Stuckey TD; Brodie BR; Yun KH; Xu K; Kirtane AJ; Stone GW; Maehara A
    Am J Cardiol; 2015 Apr; 115(7):860-6. PubMed ID: 25661569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atherosclerosis: Regression of coronary atherosclerosis with statin therapy.
    Huynh K
    Nat Rev Cardiol; 2014 Nov; 11(11):623. PubMed ID: 25245827
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy of statins on sirtuin 1 and endothelial nitric oxide synthase expression: the role of sirtuin 1 gene variants in human coronary atherosclerosis.
    Kilic U; Gok O; Elibol-Can B; Uysal O; Bacaksiz A
    Clin Exp Pharmacol Physiol; 2015 Apr; 42(4):321-30. PubMed ID: 25582759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Finally: the proof of concept--from animal studies, imaging and the clinical evidence of plaque rupture.
    Moriguchi E
    Atherosclerosis; 2010 Dec; 213(2):367-8. PubMed ID: 20970136
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.